TORONTO, July 29, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received a medical device license issued by Health Canada to market the Venus Bliss MAX™ system in Canada. The Venus Bliss MAX was first available in the United States in early 2022 and subsequently offered in approved jurisdictions around the world.

The Venus Bliss MAX™ is a 3-in-1 body shaping solution featuring three of Venus Concept’s market leading technologies in one complete platform, including diode laser for Fat Reduction treatments, our proprietary (MP)2 applicator that combines Multi-Polar Radio Frequency with Pulsed Electro Magnetic Fields and advanced VariPulse™ technology for Cellulite Reduction and Skin treatments, and the Company’s FlexMax EMS applicators for Muscle Toning and Conditioning.

“Venus continues to expand the availability of our flagship body platform, the Venus Bliss MAX, with our entry into Canada, providing our customers a comprehensive solution to deliver multiple advanced non-invasive body treatments in one system,” said Dr. Hemanth Varghese, President and Chief Operating Officer of Venus Concept. “Clinicians and aesthetic practices of all experiences and size in the Canadian market will benefit from this unique combination of proprietary technologies, further elevating the results they can deliver to the evolving aesthetic marketplace.”